She volunteered to join the inspection team. They drove eight hours to Nagpur, to the “Shree Pharma” factory. The owner, a portly man named Mr. Mehta, met them with sweet tea and a wide, oily smile.
Ananya brewed a fresh cup of coffee, opened a new file, and began to write the next chapter of the —one molecule, one test, one safe patient at a time. ipksindia
“Sir, you need to see this,” she said, walking into the office of Dr. K. S. Rajan, the secretary-cum-scientific director of the IPC. She volunteered to join the inspection team
Rajan adjusted his glasses, looking at the data. He didn't sigh or curse. He simply nodded. “The quality control failure is theirs. The public health failure is ours to prevent. Issue the alert.” Mehta, met them with sweet tea and a wide, oily smile
She was testing a batch of a common antimalarial drug, Artesunate, sent from a manufacturer in Nagpur. The label claimed it contained 500 mg of active ingredient. The machine said 120 mg. The rest was cheap fillers—chalk, starch, and a nasty binder that could cause kidney failure.